nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RXRG—Nuclear Receptors—ESR2—osteoporosis	0.00345	0.0108	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—ESR2—osteoporosis	0.00339	0.0106	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00331	0.0104	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00328	0.0103	CbGpPWpGaD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00325	0.0102	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—ESR2—osteoporosis	0.00325	0.0102	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—ESR2—osteoporosis	0.00325	0.0102	CbGpPWpGaD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00311	0.00977	CbGpPWpGaD
Isotretinoin—RARA—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00311	0.00977	CbGpPWpGaD
Isotretinoin—RXRA—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00306	0.00959	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—VDR—osteoporosis	0.003	0.00941	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00298	0.00937	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00294	0.00922	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.00282	0.00884	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptors—VDR—osteoporosis	0.00274	0.0086	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00273	0.00857	CbGpPWpGaD
Isotretinoin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—IDH2—osteoporosis	0.00272	0.00853	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—VDR—osteoporosis	0.00269	0.00844	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00268	0.0084	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—VDR—osteoporosis	0.00258	0.00809	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—VDR—osteoporosis	0.00258	0.00809	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00257	0.00805	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00257	0.00805	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00237	0.00743	CbGpPWpGaD
Isotretinoin—RXRA—Endogenous sterols—CYP19A1—osteoporosis	0.0023	0.00721	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—ESR1—osteoporosis	0.00229	0.00719	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00217	0.0068	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00212	0.00667	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptors—ESR1—osteoporosis	0.0021	0.00657	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—ESR1—osteoporosis	0.00205	0.00645	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00204	0.00639	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00204	0.00639	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00203	0.00637	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—ESR1—osteoporosis	0.00197	0.00618	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—ESR1—osteoporosis	0.00197	0.00618	CbGpPWpGaD
Isotretinoin—RXRA—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.00191	0.006	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—osteoporosis	0.00182	0.00571	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00181	0.00568	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.0017	0.00534	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—ESR2—osteoporosis	0.00169	0.00531	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—WNT1—osteoporosis	0.00169	0.00531	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.00167	0.00522	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00166	0.0052	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00165	0.00516	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00162	0.0051	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—VDR—osteoporosis	0.00162	0.00509	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00161	0.00505	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—WNT1—osteoporosis	0.00159	0.00499	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00156	0.00488	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00156	0.00488	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—BMP2—osteoporosis	0.00153	0.0048	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.0015	0.00472	CbGpPWpGaD
Isotretinoin—RXRA—Orphan transporters—ANXA2—osteoporosis	0.0015	0.00469	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.00149	0.00466	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00147	0.00462	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00144	0.00453	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—BMP2—osteoporosis	0.00144	0.00451	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.00139	0.00437	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00138	0.00434	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.00138	0.00434	CbGpPWpGaD
Isotretinoin—RXRA—Endogenous sterols—POMC—osteoporosis	0.00138	0.00433	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00138	0.00432	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00135	0.00423	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—VDR—osteoporosis	0.00134	0.00422	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00134	0.0042	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00131	0.0041	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00129	0.00406	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.00129	0.00406	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—WNT1—osteoporosis	0.00126	0.00395	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00125	0.00394	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.00108	0.0034	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00107	0.00335	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00106	0.00333	CbGpPWpGaD
Isotretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—IDH2—osteoporosis	0.00105	0.00331	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—ESR1—osteoporosis	0.00103	0.00322	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000931	0.00292	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000893	0.0028	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP27A1—osteoporosis	0.000874	0.00274	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000865	0.00271	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IRS2—osteoporosis	0.000838	0.00263	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—WNT1—osteoporosis	0.000829	0.0026	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—LEP—osteoporosis	0.00082	0.00257	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000811	0.00255	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IRS2—osteoporosis	0.000788	0.00247	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—LEP—osteoporosis	0.000771	0.00242	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.00077	0.00242	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—BMP2—osteoporosis	0.00075	0.00235	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IRS1—osteoporosis	0.000732	0.0023	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—MYC—osteoporosis	0.000723	0.00227	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.000722	0.00226	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IRS1—osteoporosis	0.000688	0.00216	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IGF1—osteoporosis	0.000678	0.00213	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.000674	0.00211	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000654	0.00205	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—U2AF1—osteoporosis	0.000648	0.00203	CbGpPWpGaD
Isotretinoin—RXRA—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000641	0.00201	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IGF1—osteoporosis	0.000637	0.002	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.000622	0.00195	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—osteoporosis	0.000611	0.00192	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—U2AF1—osteoporosis	0.000592	0.00186	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CAP1—osteoporosis	0.000592	0.00186	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000585	0.00183	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—U2AF1—osteoporosis	0.000581	0.00182	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000565	0.00177	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—U2AF1—osteoporosis	0.000557	0.00175	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—U2AF1—osteoporosis	0.000557	0.00175	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000554	0.00174	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000541	0.0017	CbGpPWpGaD
Isotretinoin—RXRA—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.00052	0.00163	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—ESR2—osteoporosis	0.000516	0.00162	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000489	0.00153	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—RPL24—osteoporosis	0.000481	0.00151	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—ESR2—osteoporosis	0.000472	0.00148	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000469	0.00147	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000465	0.00146	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—ESR2—osteoporosis	0.000462	0.00145	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—CYP19A1—osteoporosis	0.000459	0.00144	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ESR2—osteoporosis	0.000443	0.00139	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—ESR2—osteoporosis	0.000443	0.00139	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—RPL24—osteoporosis	0.00044	0.00138	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—RPL24—osteoporosis	0.000432	0.00135	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000431	0.00135	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—AGER—osteoporosis	0.000429	0.00135	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00042	0.00132	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—RPL24—osteoporosis	0.000414	0.0013	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—RPL24—osteoporosis	0.000414	0.0013	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IRS2—osteoporosis	0.000411	0.00129	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—VDR—osteoporosis	0.000409	0.00128	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TGFB1—osteoporosis	0.000406	0.00128	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—LEP—osteoporosis	0.000402	0.00126	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TGFB1—osteoporosis	0.000382	0.0012	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—TNF—osteoporosis	0.000379	0.00119	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—VDR—osteoporosis	0.000374	0.00117	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TLN1—osteoporosis	0.000371	0.00116	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—VDR—osteoporosis	0.000367	0.00115	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ACTG1—osteoporosis	0.000366	0.00115	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000365	0.00115	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IRS1—osteoporosis	0.000359	0.00113	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—TNF—osteoporosis	0.000357	0.00112	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—VDR—osteoporosis	0.000352	0.0011	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—VDR—osteoporosis	0.000352	0.0011	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000336	0.00105	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IGF1—osteoporosis	0.000332	0.00104	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—ESR1—osteoporosis	0.000313	0.000981	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IL6—osteoporosis	0.000306	0.000961	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoporosis	0.000303	0.00095	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000294	0.000922	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000293	0.000919	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—U2AF1—osteoporosis	0.00029	0.000911	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IL6—osteoporosis	0.000288	0.000903	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—ESR1—osteoporosis	0.000286	0.000897	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000285	0.000896	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—WNT1—osteoporosis	0.000285	0.000894	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—osteoporosis	0.000283	0.000887	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000282	0.000885	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000282	0.000883	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000281	0.000881	CbGpPWpGaD
Isotretinoin—Dyspnoea—Risedronate—osteoporosis	0.000281	0.000412	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—ESR1—osteoporosis	0.00028	0.00088	CbGpPWpGaD
Isotretinoin—Erythema multiforme—Estradiol—osteoporosis	0.00028	0.000411	CcSEcCtD
Isotretinoin—Hypotension—Pamidronate—osteoporosis	0.00028	0.00041	CcSEcCtD
Isotretinoin—Convulsion—Conjugated Estrogens—osteoporosis	0.000279	0.00041	CcSEcCtD
Isotretinoin—Dry mouth—Zoledronate—osteoporosis	0.000279	0.000409	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000279	0.000409	CcSEcCtD
Isotretinoin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000278	0.000408	CcSEcCtD
Isotretinoin—RARG—Gene Expression—PSMA5—osteoporosis	0.000278	0.000872	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PSMA2—osteoporosis	0.000278	0.000872	CbGpPWpGaD
Isotretinoin—Pruritus—Alendronate—osteoporosis	0.000277	0.000407	CcSEcCtD
Isotretinoin—Dyspepsia—Risedronate—osteoporosis	0.000277	0.000407	CcSEcCtD
Isotretinoin—Eye disorder—Estradiol—osteoporosis	0.000277	0.000407	CcSEcCtD
Isotretinoin—Tinnitus—Estradiol—osteoporosis	0.000276	0.000406	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—POMC—osteoporosis	0.000276	0.000866	CbGpPWpGaD
Isotretinoin—Constipation—Ethinyl Estradiol—osteoporosis	0.000276	0.000405	CcSEcCtD
Isotretinoin—Confusional state—Zoledronate—osteoporosis	0.000276	0.000404	CcSEcCtD
Isotretinoin—Hypersensitivity—Calcitriol—osteoporosis	0.000275	0.000404	CcSEcCtD
Isotretinoin—Flushing—Estradiol—osteoporosis	0.000275	0.000404	CcSEcCtD
Isotretinoin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000274	0.000403	CcSEcCtD
Isotretinoin—Myalgia—Conjugated Estrogens—osteoporosis	0.000274	0.000403	CcSEcCtD
Isotretinoin—Chest pain—Conjugated Estrogens—osteoporosis	0.000274	0.000403	CcSEcCtD
Isotretinoin—Asthenia—Ibandronate—osteoporosis	0.000274	0.000402	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000274	0.000858	CbGpPWpGaD
Isotretinoin—Anxiety—Conjugated Estrogens—osteoporosis	0.000274	0.000401	CcSEcCtD
Isotretinoin—Nausea—Etidronic acid—osteoporosis	0.000273	0.000401	CcSEcCtD
Isotretinoin—Anaphylactic shock—Zoledronate—osteoporosis	0.000273	0.000401	CcSEcCtD
Isotretinoin—Oedema—Zoledronate—osteoporosis	0.000273	0.000401	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000273	0.0004	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000273	0.0004	CcSEcCtD
Isotretinoin—Diarrhoea—Estropipate—osteoporosis	0.000272	0.0004	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000272	0.000399	CcSEcCtD
Isotretinoin—Infection—Zoledronate—osteoporosis	0.000271	0.000398	CcSEcCtD
Isotretinoin—Fatigue—Risedronate—osteoporosis	0.000271	0.000398	CcSEcCtD
Isotretinoin—Insomnia—Pamidronate—osteoporosis	0.000271	0.000397	CcSEcCtD
Isotretinoin—Pruritus—Ibandronate—osteoporosis	0.00027	0.000397	CcSEcCtD
Isotretinoin—Constipation—Risedronate—osteoporosis	0.000269	0.000395	CcSEcCtD
Isotretinoin—Pain—Risedronate—osteoporosis	0.000269	0.000395	CcSEcCtD
Isotretinoin—Angiopathy—Estradiol—osteoporosis	0.000269	0.000395	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—ESR1—osteoporosis	0.000269	0.000844	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—ESR1—osteoporosis	0.000269	0.000844	CbGpPWpGaD
Isotretinoin—Shock—Zoledronate—osteoporosis	0.000269	0.000395	CcSEcCtD
Isotretinoin—Paraesthesia—Pamidronate—osteoporosis	0.000269	0.000394	CcSEcCtD
Isotretinoin—Diarrhoea—Alendronate—osteoporosis	0.000268	0.000394	CcSEcCtD
Isotretinoin—Asthenia—Calcitriol—osteoporosis	0.000268	0.000394	CcSEcCtD
Isotretinoin—Nervous system disorder—Zoledronate—osteoporosis	0.000268	0.000393	CcSEcCtD
Isotretinoin—Thrombocytopenia—Zoledronate—osteoporosis	0.000268	0.000393	CcSEcCtD
Isotretinoin—Dyspnoea—Pamidronate—osteoporosis	0.000267	0.000391	CcSEcCtD
Isotretinoin—Tachycardia—Zoledronate—osteoporosis	0.000267	0.000391	CcSEcCtD
Isotretinoin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000266	0.00039	CcSEcCtD
Isotretinoin—Chills—Estradiol—osteoporosis	0.000266	0.00039	CcSEcCtD
Isotretinoin—Somnolence—Pamidronate—osteoporosis	0.000266	0.00039	CcSEcCtD
Isotretinoin—Skin disorder—Zoledronate—osteoporosis	0.000265	0.00039	CcSEcCtD
Isotretinoin—Pruritus—Calcitriol—osteoporosis	0.000264	0.000388	CcSEcCtD
Isotretinoin—Hyperhidrosis—Zoledronate—osteoporosis	0.000264	0.000388	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000264	0.000387	CcSEcCtD
Isotretinoin—Diarrhoea—Raloxifene—osteoporosis	0.000264	0.000387	CcSEcCtD
Isotretinoin—Dyspepsia—Pamidronate—osteoporosis	0.000263	0.000387	CcSEcCtD
Isotretinoin—Dizziness—Estropipate—osteoporosis	0.000263	0.000387	CcSEcCtD
Isotretinoin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000263	0.000386	CcSEcCtD
Isotretinoin—Oedema—Conjugated Estrogens—osteoporosis	0.000263	0.000386	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000262	0.000823	CbGpPWpGaD
Isotretinoin—Alopecia—Estradiol—osteoporosis	0.000262	0.000384	CcSEcCtD
Isotretinoin—Infection—Conjugated Estrogens—osteoporosis	0.000261	0.000384	CcSEcCtD
Isotretinoin—Diarrhoea—Ibandronate—osteoporosis	0.000261	0.000383	CcSEcCtD
Isotretinoin—Anorexia—Zoledronate—osteoporosis	0.00026	0.000382	CcSEcCtD
Isotretinoin—RXRA—Metabolism—FDPS—osteoporosis	0.00026	0.000817	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PKM—osteoporosis	0.00026	0.000817	CbGpPWpGaD
Isotretinoin—Decreased appetite—Pamidronate—osteoporosis	0.00026	0.000382	CcSEcCtD
Isotretinoin—Mental disorder—Estradiol—osteoporosis	0.00026	0.000381	CcSEcCtD
Isotretinoin—Dizziness—Alendronate—osteoporosis	0.000259	0.000381	CcSEcCtD
Isotretinoin—Shock—Conjugated Estrogens—osteoporosis	0.000259	0.00038	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000258	0.000379	CcSEcCtD
Isotretinoin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000258	0.000379	CcSEcCtD
Isotretinoin—Erythema—Estradiol—osteoporosis	0.000258	0.000379	CcSEcCtD
Isotretinoin—Malnutrition—Estradiol—osteoporosis	0.000258	0.000379	CcSEcCtD
Isotretinoin—Fatigue—Pamidronate—osteoporosis	0.000258	0.000379	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Risedronate—osteoporosis	0.000257	0.000378	CcSEcCtD
Isotretinoin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000257	0.000377	CcSEcCtD
Isotretinoin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000256	0.000376	CcSEcCtD
Isotretinoin—Pain—Pamidronate—osteoporosis	0.000256	0.000375	CcSEcCtD
Isotretinoin—Constipation—Pamidronate—osteoporosis	0.000256	0.000375	CcSEcCtD
Isotretinoin—Diarrhoea—Calcitriol—osteoporosis	0.000256	0.000375	CcSEcCtD
Isotretinoin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000256	0.000375	CcSEcCtD
Isotretinoin—Hypotension—Zoledronate—osteoporosis	0.000255	0.000375	CcSEcCtD
Isotretinoin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000255	0.000375	CcSEcCtD
Isotretinoin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000255	0.000375	CcSEcCtD
Isotretinoin—Dizziness—Raloxifene—osteoporosis	0.000255	0.000374	CcSEcCtD
Isotretinoin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000254	0.000373	CcSEcCtD
Isotretinoin—Flatulence—Estradiol—osteoporosis	0.000254	0.000373	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—PSMA5—osteoporosis	0.000254	0.000797	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PSMA2—osteoporosis	0.000254	0.000797	CbGpPWpGaD
Isotretinoin—Tension—Estradiol—osteoporosis	0.000253	0.000372	CcSEcCtD
Isotretinoin—Vomiting—Estropipate—osteoporosis	0.000253	0.000372	CcSEcCtD
Isotretinoin—Dizziness—Ibandronate—osteoporosis	0.000253	0.000371	CcSEcCtD
Isotretinoin—Rash—Estropipate—osteoporosis	0.000251	0.000369	CcSEcCtD
Isotretinoin—Dermatitis—Estropipate—osteoporosis	0.000251	0.000368	CcSEcCtD
Isotretinoin—Anorexia—Conjugated Estrogens—osteoporosis	0.000251	0.000368	CcSEcCtD
Isotretinoin—Nervousness—Estradiol—osteoporosis	0.000251	0.000368	CcSEcCtD
Isotretinoin—Urticaria—Risedronate—osteoporosis	0.00025	0.000367	CcSEcCtD
Isotretinoin—Back pain—Estradiol—osteoporosis	0.00025	0.000366	CcSEcCtD
Isotretinoin—Headache—Estropipate—osteoporosis	0.000249	0.000366	CcSEcCtD
Isotretinoin—Vomiting—Alendronate—osteoporosis	0.000249	0.000366	CcSEcCtD
Isotretinoin—RARB—Gene Expression—PSMA5—osteoporosis	0.000249	0.000782	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PSMA2—osteoporosis	0.000249	0.000782	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000249	0.000365	CcSEcCtD
Isotretinoin—Abdominal pain—Risedronate—osteoporosis	0.000249	0.000365	CcSEcCtD
Isotretinoin—Body temperature increased—Risedronate—osteoporosis	0.000249	0.000365	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ESR2—osteoporosis	0.000248	0.000779	CbGpPWpGaD
Isotretinoin—Rash—Alendronate—osteoporosis	0.000247	0.000363	CcSEcCtD
Isotretinoin—Insomnia—Zoledronate—osteoporosis	0.000247	0.000363	CcSEcCtD
Isotretinoin—Dermatitis—Alendronate—osteoporosis	0.000247	0.000363	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PGLS—osteoporosis	0.000247	0.000774	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GPD2—osteoporosis	0.000247	0.000774	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Pamidronate—osteoporosis	0.000247	0.000362	CcSEcCtD
Isotretinoin—Hypotension—Conjugated Estrogens—osteoporosis	0.000246	0.000361	CcSEcCtD
Isotretinoin—Headache—Alendronate—osteoporosis	0.000246	0.000361	CcSEcCtD
Isotretinoin—Paraesthesia—Zoledronate—osteoporosis	0.000245	0.00036	CcSEcCtD
Isotretinoin—Vomiting—Raloxifene—osteoporosis	0.000245	0.00036	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000245	0.000359	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000244	0.000766	CbGpPWpGaD
Isotretinoin—Dyspnoea—Zoledronate—osteoporosis	0.000244	0.000358	CcSEcCtD
Isotretinoin—Rash—Raloxifene—osteoporosis	0.000243	0.000357	CcSEcCtD
Isotretinoin—Dermatitis—Raloxifene—osteoporosis	0.000243	0.000357	CcSEcCtD
Isotretinoin—Somnolence—Zoledronate—osteoporosis	0.000243	0.000357	CcSEcCtD
Isotretinoin—Vomiting—Ibandronate—osteoporosis	0.000243	0.000356	CcSEcCtD
Isotretinoin—Tremor—Estradiol—osteoporosis	0.000242	0.000355	CcSEcCtD
Isotretinoin—Headache—Raloxifene—osteoporosis	0.000242	0.000355	CcSEcCtD
Isotretinoin—Rash—Ibandronate—osteoporosis	0.000241	0.000353	CcSEcCtD
Isotretinoin—Dermatitis—Ibandronate—osteoporosis	0.000241	0.000353	CcSEcCtD
Isotretinoin—Dyspepsia—Zoledronate—osteoporosis	0.000241	0.000353	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00024	0.000352	CcSEcCtD
Isotretinoin—Ill-defined disorder—Estradiol—osteoporosis	0.000239	0.000351	CcSEcCtD
Isotretinoin—Headache—Ibandronate—osteoporosis	0.000239	0.000351	CcSEcCtD
Isotretinoin—RARA—Gene Expression—PSMA5—osteoporosis	0.000239	0.00075	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PSMA5—osteoporosis	0.000239	0.00075	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PSMA2—osteoporosis	0.000239	0.00075	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PSMA2—osteoporosis	0.000239	0.00075	CbGpPWpGaD
Isotretinoin—Insomnia—Conjugated Estrogens—osteoporosis	0.000238	0.000349	CcSEcCtD
Isotretinoin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000238	0.000349	CcSEcCtD
Isotretinoin—Vomiting—Calcitriol—osteoporosis	0.000238	0.000349	CcSEcCtD
Isotretinoin—Decreased appetite—Zoledronate—osteoporosis	0.000238	0.000349	CcSEcCtD
Isotretinoin—Agitation—Estradiol—osteoporosis	0.000237	0.000348	CcSEcCtD
Isotretinoin—Nausea—Estropipate—osteoporosis	0.000237	0.000347	CcSEcCtD
Isotretinoin—Body temperature increased—Pamidronate—osteoporosis	0.000236	0.000347	CcSEcCtD
Isotretinoin—Abdominal pain—Pamidronate—osteoporosis	0.000236	0.000347	CcSEcCtD
Isotretinoin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000236	0.000347	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000236	0.000346	CcSEcCtD
Isotretinoin—Rash—Calcitriol—osteoporosis	0.000236	0.000346	CcSEcCtD
Isotretinoin—Fatigue—Zoledronate—osteoporosis	0.000236	0.000346	CcSEcCtD
Isotretinoin—Dermatitis—Calcitriol—osteoporosis	0.000235	0.000346	CcSEcCtD
Isotretinoin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000235	0.000344	CcSEcCtD
Isotretinoin—Headache—Calcitriol—osteoporosis	0.000234	0.000344	CcSEcCtD
Isotretinoin—Somnolence—Conjugated Estrogens—osteoporosis	0.000234	0.000343	CcSEcCtD
Isotretinoin—Pain—Zoledronate—osteoporosis	0.000234	0.000343	CcSEcCtD
Isotretinoin—Constipation—Zoledronate—osteoporosis	0.000234	0.000343	CcSEcCtD
Isotretinoin—Nausea—Alendronate—osteoporosis	0.000233	0.000342	CcSEcCtD
Isotretinoin—Malaise—Estradiol—osteoporosis	0.000233	0.000342	CcSEcCtD
Isotretinoin—Hypersensitivity—Risedronate—osteoporosis	0.000232	0.00034	CcSEcCtD
Isotretinoin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000232	0.00034	CcSEcCtD
Isotretinoin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000232	0.00034	CcSEcCtD
Isotretinoin—Syncope—Estradiol—osteoporosis	0.000231	0.00034	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR2—osteoporosis	0.000231	0.000725	CbGpPWpGaD
Isotretinoin—Nausea—Raloxifene—osteoporosis	0.000229	0.000336	CcSEcCtD
Isotretinoin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000229	0.000336	CcSEcCtD
Isotretinoin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000228	0.000335	CcSEcCtD
Isotretinoin—Palpitations—Estradiol—osteoporosis	0.000228	0.000335	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000227	0.000333	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ESR2—osteoporosis	0.000227	0.000712	CbGpPWpGaD
Isotretinoin—Fatigue—Conjugated Estrogens—osteoporosis	0.000227	0.000333	CcSEcCtD
Isotretinoin—Nausea—Ibandronate—osteoporosis	0.000227	0.000333	CcSEcCtD
Isotretinoin—Loss of consciousness—Estradiol—osteoporosis	0.000227	0.000333	CcSEcCtD
Isotretinoin—Asthenia—Risedronate—osteoporosis	0.000226	0.000331	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ATIC—osteoporosis	0.000226	0.000708	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PNP—osteoporosis	0.000226	0.000708	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Zoledronate—osteoporosis	0.000225	0.000331	CcSEcCtD
Isotretinoin—Cough—Estradiol—osteoporosis	0.000225	0.00033	CcSEcCtD
Isotretinoin—Pain—Conjugated Estrogens—osteoporosis	0.000225	0.00033	CcSEcCtD
Isotretinoin—Constipation—Conjugated Estrogens—osteoporosis	0.000225	0.00033	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000223	0.000328	CcSEcCtD
Isotretinoin—Hypertension—Estradiol—osteoporosis	0.000223	0.000327	CcSEcCtD
Isotretinoin—Pruritus—Risedronate—osteoporosis	0.000223	0.000327	CcSEcCtD
Isotretinoin—RARB—Gene Expression—ESR2—osteoporosis	0.000223	0.000699	CbGpPWpGaD
Isotretinoin—Nausea—Calcitriol—osteoporosis	0.000222	0.000326	CcSEcCtD
Isotretinoin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000221	0.000324	CcSEcCtD
Isotretinoin—Hypersensitivity—Pamidronate—osteoporosis	0.00022	0.000324	CcSEcCtD
Isotretinoin—Arthralgia—Estradiol—osteoporosis	0.00022	0.000322	CcSEcCtD
Isotretinoin—Chest pain—Estradiol—osteoporosis	0.00022	0.000322	CcSEcCtD
Isotretinoin—Myalgia—Estradiol—osteoporosis	0.00022	0.000322	CcSEcCtD
Isotretinoin—Anxiety—Estradiol—osteoporosis	0.000219	0.000321	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000218	0.00032	CcSEcCtD
Isotretinoin—Urticaria—Zoledronate—osteoporosis	0.000217	0.000319	CcSEcCtD
Isotretinoin—Discomfort—Estradiol—osteoporosis	0.000217	0.000319	CcSEcCtD
Isotretinoin—Abdominal pain—Zoledronate—osteoporosis	0.000216	0.000317	CcSEcCtD
Isotretinoin—Body temperature increased—Zoledronate—osteoporosis	0.000216	0.000317	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—RPL24—osteoporosis	0.000216	0.000677	CbGpPWpGaD
Isotretinoin—Diarrhoea—Risedronate—osteoporosis	0.000215	0.000316	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000215	0.000316	CcSEcCtD
Isotretinoin—Dry mouth—Estradiol—osteoporosis	0.000215	0.000315	CcSEcCtD
Isotretinoin—Asthenia—Pamidronate—osteoporosis	0.000215	0.000315	CcSEcCtD
Isotretinoin—RARA—Gene Expression—ESR2—osteoporosis	0.000213	0.00067	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ESR2—osteoporosis	0.000213	0.00067	CbGpPWpGaD
Isotretinoin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000213	0.000313	CcSEcCtD
Isotretinoin—Confusional state—Estradiol—osteoporosis	0.000212	0.000312	CcSEcCtD
Isotretinoin—Pruritus—Pamidronate—osteoporosis	0.000212	0.000311	CcSEcCtD
Isotretinoin—Oedema—Estradiol—osteoporosis	0.000211	0.000309	CcSEcCtD
Isotretinoin—Anaphylactic shock—Estradiol—osteoporosis	0.000211	0.000309	CcSEcCtD
Isotretinoin—Infection—Estradiol—osteoporosis	0.000209	0.000307	CcSEcCtD
Isotretinoin—Urticaria—Conjugated Estrogens—osteoporosis	0.000209	0.000307	CcSEcCtD
Isotretinoin—Dizziness—Risedronate—osteoporosis	0.000208	0.000305	CcSEcCtD
Isotretinoin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000208	0.000305	CcSEcCtD
Isotretinoin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000208	0.000305	CcSEcCtD
Isotretinoin—Shock—Estradiol—osteoporosis	0.000207	0.000304	CcSEcCtD
Isotretinoin—Nervous system disorder—Estradiol—osteoporosis	0.000207	0.000303	CcSEcCtD
Isotretinoin—Tachycardia—Estradiol—osteoporosis	0.000206	0.000302	CcSEcCtD
Isotretinoin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000205	0.000301	CcSEcCtD
Isotretinoin—Diarrhoea—Pamidronate—osteoporosis	0.000205	0.0003	CcSEcCtD
Isotretinoin—Skin disorder—Estradiol—osteoporosis	0.000205	0.0003	CcSEcCtD
Isotretinoin—Hyperhidrosis—Estradiol—osteoporosis	0.000204	0.000299	CcSEcCtD
Isotretinoin—Rash—Ethinyl Estradiol—osteoporosis	0.000204	0.000299	CcSEcCtD
Isotretinoin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000203	0.000298	CcSEcCtD
Isotretinoin—Headache—Ethinyl Estradiol—osteoporosis	0.000202	0.000297	CcSEcCtD
Isotretinoin—Hypersensitivity—Zoledronate—osteoporosis	0.000201	0.000296	CcSEcCtD
Isotretinoin—Vomiting—Risedronate—osteoporosis	0.0002	0.000294	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—TGFB1—osteoporosis	0.000199	0.000625	CbGpPWpGaD
Isotretinoin—Rash—Risedronate—osteoporosis	0.000198	0.000291	CcSEcCtD
Isotretinoin—Dermatitis—Risedronate—osteoporosis	0.000198	0.000291	CcSEcCtD
Isotretinoin—Dizziness—Pamidronate—osteoporosis	0.000198	0.00029	CcSEcCtD
Isotretinoin—Headache—Risedronate—osteoporosis	0.000197	0.000289	CcSEcCtD
Isotretinoin—RARG—Gene Expression—VDR—osteoporosis	0.000197	0.000618	CbGpPWpGaD
Isotretinoin—Asthenia—Zoledronate—osteoporosis	0.000196	0.000288	CcSEcCtD
Isotretinoin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000194	0.000285	CcSEcCtD
Isotretinoin—Pruritus—Zoledronate—osteoporosis	0.000193	0.000284	CcSEcCtD
Isotretinoin—RXRA—Metabolism—OXCT1—osteoporosis	0.000192	0.000602	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CA2—osteoporosis	0.000192	0.000602	CbGpPWpGaD
Isotretinoin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000192	0.000282	CcSEcCtD
Isotretinoin—Nausea—Ethinyl Estradiol—osteoporosis	0.000192	0.000281	CcSEcCtD
Isotretinoin—Insomnia—Estradiol—osteoporosis	0.00019	0.00028	CcSEcCtD
Isotretinoin—Vomiting—Pamidronate—osteoporosis	0.00019	0.000279	CcSEcCtD
Isotretinoin—Paraesthesia—Estradiol—osteoporosis	0.000189	0.000278	CcSEcCtD
Isotretinoin—Asthenia—Conjugated Estrogens—osteoporosis	0.000189	0.000277	CcSEcCtD
Isotretinoin—Rash—Pamidronate—osteoporosis	0.000189	0.000277	CcSEcCtD
Isotretinoin—Dermatitis—Pamidronate—osteoporosis	0.000188	0.000277	CcSEcCtD
Isotretinoin—Dyspnoea—Estradiol—osteoporosis	0.000188	0.000276	CcSEcCtD
Isotretinoin—Headache—Pamidronate—osteoporosis	0.000187	0.000275	CcSEcCtD
Isotretinoin—Somnolence—Estradiol—osteoporosis	0.000187	0.000275	CcSEcCtD
Isotretinoin—RXRA—Metabolism—MGLL—osteoporosis	0.000187	0.000587	CbGpPWpGaD
Isotretinoin—Diarrhoea—Zoledronate—osteoporosis	0.000187	0.000274	CcSEcCtD
Isotretinoin—Nausea—Risedronate—osteoporosis	0.000187	0.000274	CcSEcCtD
Isotretinoin—Pruritus—Conjugated Estrogens—osteoporosis	0.000186	0.000273	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—TNF—osteoporosis	0.000186	0.000583	CbGpPWpGaD
Isotretinoin—Dyspepsia—Estradiol—osteoporosis	0.000185	0.000272	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—VDR—osteoporosis	0.000183	0.000575	CbGpPWpGaD
Isotretinoin—Decreased appetite—Estradiol—osteoporosis	0.000183	0.000269	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000182	0.000267	CcSEcCtD
Isotretinoin—Fatigue—Estradiol—osteoporosis	0.000182	0.000266	CcSEcCtD
Isotretinoin—RXRA—NRF2 pathway—TGFB1—osteoporosis	0.000181	0.000569	CbGpPWpGaD
Isotretinoin—Dizziness—Zoledronate—osteoporosis	0.000181	0.000265	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—VDR—osteoporosis	0.00018	0.000565	CbGpPWpGaD
Isotretinoin—Pain—Estradiol—osteoporosis	0.00018	0.000264	CcSEcCtD
Isotretinoin—Constipation—Estradiol—osteoporosis	0.00018	0.000264	CcSEcCtD
Isotretinoin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00018	0.000264	CcSEcCtD
Isotretinoin—Nausea—Pamidronate—osteoporosis	0.000178	0.000261	CcSEcCtD
Isotretinoin—RARB—Gene Expression—VDR—osteoporosis	0.000177	0.000554	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000176	0.000553	CbGpPWpGaD
Isotretinoin—Dizziness—Conjugated Estrogens—osteoporosis	0.000174	0.000255	CcSEcCtD
Isotretinoin—Vomiting—Zoledronate—osteoporosis	0.000174	0.000255	CcSEcCtD
Isotretinoin—Feeling abnormal—Estradiol—osteoporosis	0.000174	0.000255	CcSEcCtD
Isotretinoin—Rash—Zoledronate—osteoporosis	0.000172	0.000253	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Estradiol—osteoporosis	0.000172	0.000253	CcSEcCtD
Isotretinoin—Dermatitis—Zoledronate—osteoporosis	0.000172	0.000253	CcSEcCtD
Isotretinoin—Headache—Zoledronate—osteoporosis	0.000171	0.000251	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—VDR—osteoporosis	0.000169	0.000532	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—VDR—osteoporosis	0.000169	0.000532	CbGpPWpGaD
Isotretinoin—Vomiting—Conjugated Estrogens—osteoporosis	0.000167	0.000246	CcSEcCtD
Isotretinoin—Urticaria—Estradiol—osteoporosis	0.000167	0.000246	CcSEcCtD
Isotretinoin—Body temperature increased—Estradiol—osteoporosis	0.000166	0.000244	CcSEcCtD
Isotretinoin—Abdominal pain—Estradiol—osteoporosis	0.000166	0.000244	CcSEcCtD
Isotretinoin—Rash—Conjugated Estrogens—osteoporosis	0.000166	0.000244	CcSEcCtD
Isotretinoin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000166	0.000243	CcSEcCtD
Isotretinoin—Headache—Conjugated Estrogens—osteoporosis	0.000165	0.000242	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—osteoporosis	0.000163	0.00051	CbGpPWpGaD
Isotretinoin—Nausea—Zoledronate—osteoporosis	0.000162	0.000238	CcSEcCtD
Isotretinoin—RXRA—Metabolism—IDH2—osteoporosis	0.000159	0.000499	CbGpPWpGaD
Isotretinoin—Nausea—Conjugated Estrogens—osteoporosis	0.000156	0.000229	CcSEcCtD
Isotretinoin—Hypersensitivity—Estradiol—osteoporosis	0.000155	0.000228	CcSEcCtD
Isotretinoin—Asthenia—Estradiol—osteoporosis	0.000151	0.000222	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ESR1—osteoporosis	0.000151	0.000472	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—IL6—osteoporosis	0.00015	0.000471	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP27A1—osteoporosis	0.00015	0.000469	CbGpPWpGaD
Isotretinoin—Pruritus—Estradiol—osteoporosis	0.000149	0.000219	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—osteoporosis	0.000149	0.000467	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000147	0.00046	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000146	0.000459	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—osteoporosis	0.000146	0.000458	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ACP5—osteoporosis	0.000145	0.000456	CbGpPWpGaD
Isotretinoin—Diarrhoea—Estradiol—osteoporosis	0.000144	0.000211	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000144	0.000451	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—ESR1—osteoporosis	0.00014	0.00044	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—osteoporosis	0.00014	0.000439	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—osteoporosis	0.00014	0.000439	CbGpPWpGaD
Isotretinoin—Dizziness—Estradiol—osteoporosis	0.000139	0.000204	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—LEP—osteoporosis	0.000138	0.000434	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—ESR1—osteoporosis	0.000138	0.000432	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000137	0.00043	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000137	0.000429	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TPI1—osteoporosis	0.000135	0.000424	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ESR1—osteoporosis	0.000135	0.000424	CbGpPWpGaD
Isotretinoin—Vomiting—Estradiol—osteoporosis	0.000134	0.000197	CcSEcCtD
Isotretinoin—Rash—Estradiol—osteoporosis	0.000133	0.000195	CcSEcCtD
Isotretinoin—Dermatitis—Estradiol—osteoporosis	0.000133	0.000195	CcSEcCtD
Isotretinoin—Headache—Estradiol—osteoporosis	0.000132	0.000194	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—ESR1—osteoporosis	0.000129	0.000406	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ESR1—osteoporosis	0.000129	0.000406	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—P4HB—osteoporosis	0.000127	0.000399	CbGpPWpGaD
Isotretinoin—Nausea—Estradiol—osteoporosis	0.000125	0.000184	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GAPDH—osteoporosis	0.000125	0.000392	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PSMA2—osteoporosis	0.000125	0.000391	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PSMA5—osteoporosis	0.000125	0.000391	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—RAP1A—osteoporosis	0.000122	0.000381	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6R—osteoporosis	0.000116	0.000363	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR2—osteoporosis	0.000111	0.000349	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000106	0.000333	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ENO1—osteoporosis	9.83e-05	0.000308	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PSMA2—osteoporosis	9.68e-05	0.000304	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PSMA5—osteoporosis	9.68e-05	0.000304	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—VDR—osteoporosis	8.83e-05	0.000277	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP19A1—osteoporosis	7.85e-05	0.000246	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—osteoporosis	7.83e-05	0.000246	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—osteoporosis	7.29e-05	0.000229	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—osteoporosis	7.16e-05	0.000225	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—osteoporosis	7.02e-05	0.00022	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TGFB1—osteoporosis	6.84e-05	0.000215	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—ESR1—osteoporosis	6.75e-05	0.000212	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—osteoporosis	6.73e-05	0.000211	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—osteoporosis	6.73e-05	0.000211	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ADCY5—osteoporosis	6.42e-05	0.000201	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GPX1—osteoporosis	6.4e-05	0.000201	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—TNF—osteoporosis	6.39e-05	0.000201	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—MTHFR—osteoporosis	5.9e-05	0.000185	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6—osteoporosis	5.16e-05	0.000162	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—POMC—osteoporosis	4.72e-05	0.000148	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—osteoporosis	3.51e-05	0.00011	CbGpPWpGaD
